Suppr超能文献

弥漫性大B细胞淋巴瘤中的TET2突变

TET2 mutation in diffuse large B-cell lymphoma.

作者信息

Kubuki Yoko, Yamaji Takumi, Hidaka Tomonori, Kameda Takuro, Shide Kotaro, Sekine Masaaki, Kamiunten Ayako, Akizuki Keiichi, Shimoda Haruko, Tahira Yuuki, Nakamura Kenichi, Abe Hiroo, Miike Tadashi, Iwakiri Hisayoshi, Tahara Yoshihiro, Sueta Mitsue, Yamamoto Shojiro, Hasuike Satoru, Nagata Kenji, Kitanaka Akira, Shimoda Kazuya

机构信息

Department of Transfusion and Cell Therapy, University of Miyazaki Hospital.

出版信息

J Clin Exp Hematop. 2017;56(3):145-149. doi: 10.3960/jslrt.56.145.

Abstract

Ten-eleven translocation-2 (TET2) mutation is frequently observed in myeloid malignancies, and loss-of-function of TET2 is essential for the initiation of malignant hematopoiesis. TET2 mutation presents across disease entities and was reported in lymphoid malignancies. We investigated TET2 mutations in 27 diffuse large B-cell lymphoma (DLBCL) patients and found a frameshift mutation in 1 case (3.7%). TET2 mutation occurred in some populations of DLBCL patients and was likely involved in the pathogenesis of their malignancies.

摘要

十一-易位蛋白2(TET2)突变在髓系恶性肿瘤中经常被观察到,并且TET2功能丧失对于恶性造血的起始至关重要。TET2突变存在于多种疾病实体中,并且在淋巴系恶性肿瘤中也有报道。我们调查了27例弥漫性大B细胞淋巴瘤(DLBCL)患者的TET2突变情况,发现1例患者存在移码突变(3.7%)。TET2突变发生在部分DLBCL患者群体中,可能参与了其恶性肿瘤的发病机制。

相似文献

1
TET2 mutation in diffuse large B-cell lymphoma.
J Clin Exp Hematop. 2017;56(3):145-149. doi: 10.3960/jslrt.56.145.
2
TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
J Clin Exp Hematop. 2015;55(3):145-9. doi: 10.3960/jslrt.55.145.
3
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Haematologica. 2013 Dec;98(12):1912-20. doi: 10.3324/haematol.2013.088740. Epub 2013 Jul 5.
4
Dysregulation of TET2 in hematologic malignancies.
Int J Hematol. 2017 Jan;105(1):17-22. doi: 10.1007/s12185-016-2122-z. Epub 2016 Nov 15.
5
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Leukemia. 2014 Mar;28(3):485-96. doi: 10.1038/leu.2013.337. Epub 2013 Nov 13.
6
The TET2 interactors and their links to hematological malignancies.
IUBMB Life. 2015 Jun;67(6):438-45. doi: 10.1002/iub.1389. Epub 2015 Jun 22.
7
[TET2 as a gatekeeper for hematologic malignancies].
Rinsho Ketsueki. 2015 Jun;56(6):651-6. doi: 10.11406/rinketsu.56.651.
8
Antibiotic treatment ameliorates Ten-eleven translocation 2 (TET2) loss-of-function associated hematological malignancies.
Cancer Lett. 2019 Dec 28;467:1-8. doi: 10.1016/j.canlet.2019.09.013. Epub 2019 Sep 26.
9
10
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis.
Cancer Discov. 2018 Dec;8(12):1632-1653. doi: 10.1158/2159-8290.CD-18-0657. Epub 2018 Oct 1.

引用本文的文献

1
Epigenetic Symphony in Diffuse Large B-Cell Lymphoma: Orchestrating the Tumor Microenvironment.
Biomedicines. 2025 Apr 2;13(4):853. doi: 10.3390/biomedicines13040853.
2
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review.
Int J Mol Sci. 2024 Oct 23;25(21):11384. doi: 10.3390/ijms252111384.
3
Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity.
Front Immunol. 2024 Mar 27;15:1380641. doi: 10.3389/fimmu.2024.1380641. eCollection 2024.
4
Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review.
Neuro Oncol. 2024 Jun 3;26(6):993-1011. doi: 10.1093/neuonc/noae032.
5
TET2 mutation as prototypic clonal hematopoiesis lesion.
Semin Hematol. 2024 Feb;61(1):51-60. doi: 10.1053/j.seminhematol.2024.01.013. Epub 2024 Feb 2.
6
Clinical and Mechanistic Implications of R-Loops in Human Leukemias.
Int J Mol Sci. 2023 Mar 22;24(6):5966. doi: 10.3390/ijms24065966.
7
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
Signal Transduct Target Ther. 2023 Feb 17;8(1):71. doi: 10.1038/s41392-023-01342-6.
8
Active DNA demethylation-The epigenetic gatekeeper of development, immunity, and cancer.
Adv Genet (Hoboken). 2020 Nov 27;2(1):e10033. doi: 10.1002/ggn2.10033. eCollection 2021 Mar.
10
Concurrent lung adenocarcinoma and bladder diffuse large B-cell lymphoma: a case report and literature review.
J Int Med Res. 2022 Feb;50(2):3000605221081672. doi: 10.1177/03000605221081672.

本文引用的文献

1
TET2 Mutation in Adult T-Cell Leukemia/Lymphoma.
J Clin Exp Hematop. 2015;55(3):145-9. doi: 10.3960/jslrt.55.145.
2
Integrated molecular analysis of adult T cell leukemia/lymphoma.
Nat Genet. 2015 Nov;47(11):1304-15. doi: 10.1038/ng.3415. Epub 2015 Oct 5.
3
Pathogenesis, diagnosis, and treatment of composite lymphomas.
Lancet Oncol. 2014 Sep;15(10):e435-46. doi: 10.1016/S1470-2045(14)70153-6.
4
Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Nat Genet. 2014 Feb;46(2):171-5. doi: 10.1038/ng.2872. Epub 2014 Jan 12.
5
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.
Blood. 2014 Feb 27;123(9):1293-6. doi: 10.1182/blood-2013-10-531509. Epub 2013 Dec 17.
6
The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases.
Leukemia. 2014 Mar;28(3):485-96. doi: 10.1038/leu.2013.337. Epub 2013 Nov 13.
7
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma.
Haematologica. 2013 Dec;98(12):1912-20. doi: 10.3324/haematol.2013.088740. Epub 2013 Jul 5.
8
Cancer genome landscapes.
Science. 2013 Mar 29;339(6127):1546-58. doi: 10.1126/science.1235122.
9
Targeting pathological B cell receptor signalling in lymphoid malignancies.
Nat Rev Drug Discov. 2013 Mar;12(3):229-43. doi: 10.1038/nrd3937.
10
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.
Nat Genet. 2012 Nov;44(11):1179-81. doi: 10.1038/ng.2413. Epub 2012 Sep 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验